Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management
- DOI
- 10.3390/cancers18183041
- Published
- 2026-09-19
- Container
- Cancers
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18183041,
title = {Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management},
author = {Andrea Bottardi and Gabriele Busin and Lam Nguyen and Paolo Del Fiore and Giorgia Alberti and Andrea Danese and Michele Nori and Raimondo Pittorru and Fortunato Cassalia},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18183041},
url = {https://doi.org/10.3390/cancers18183041}
}RIS
TY - JOUR TI - Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management AU - Andrea Bottardi AU - Gabriele Busin AU - Lam Nguyen AU - Paolo Del Fiore AU - Giorgia Alberti AU - Andrea Danese AU - Michele Nori AU - Raimondo Pittorru AU - Fortunato Cassalia PY - 2026 JO - Cancers DO - 10.3390/cancers18183041 UR - https://doi.org/10.3390/cancers18183041 ER -
APA
Bottardi, A., Busin, G., Nguyen, L., Fiore, P. D., Alberti, G., Danese, A., Nori, M., Pittorru, R., & Cassalia, F. (2026). Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management. Cancers. https://doi.org/10.3390/cancers18183041
Source records
- crossref · retrieved 2026-09-26T13:28:49.266Z